KRYSTAL BIOTECH INC. - COMMON STOCK

Krystal Biotech Provides Update on Pivotal GEM-3 Study of B-VEC for DEB

26 4 2021 15:05:00 提供 Nasdaq GlobeNewswire

Krystal Biotech Provides Updates from its Rare Genetic Lung Disease Pipeline

19 4 2021 07:00:01 提供 Nasdaq GlobeNewswire

Krystal Biotech Announces Completion of Patient Enrollment in the GEM-3 Pivotal Trial of B-VEC for the Treatment of Dystrophic Epidermolysis Bullosa

30 3 2021 07:00:02 提供 Nasdaq GlobeNewswire

Krystal Biotech to Participate in Upcoming Investor Conferences

29 3 2021 15:30:00 提供 Nasdaq GlobeNewswire

Krystal Biotech Announces Launch of Jeune, a Gene-Based Aesthetics Company, and Initial Phase 1 Safety Data for KB301 in Aesthetic Indications

24 3 2021 06:00:00 提供 Nasdaq GlobeNewswire

Krystal Biotech Provides Update on Operational Progress and Reports Fourth Quarter and Full Year 2020 Financial Results

01 3 2021 07:37:30 提供 Nasdaq GlobeNewswire

Krystal Biotech to Present at the Cowen 41st Annual Health Care Conference

23 2 2021 07:00:01 提供 Nasdaq GlobeNewswire

Krystal Biotech Announces Pricing of Upsized $125 Million Public Offering of Common Stock

02 2 2021 19:50:57 提供 Nasdaq GlobeNewswire